A detailed history of Mv Capital Management, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Mv Capital Management, Inc. holds 391 shares of ZTS stock, worth $69,105. This represents 0.01% of its overall portfolio holdings.

Number of Shares
391
Previous 381 2.62%
Holding current value
$69,105
Previous $66,000 15.15%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$172.58 - $196.48 $1,725 - $1,964
10 Added 2.62%
391 $76,000
Q2 2024

Aug 01, 2024

SELL
$145.54 - $178.83 $6,403 - $7,868
-44 Reduced 10.35%
381 $66,000
Q1 2024

Apr 18, 2024

BUY
$165.67 - $199.94 $1,491 - $1,799
9 Added 2.16%
425 $71,000
Q4 2023

Jan 29, 2024

SELL
$151.44 - $200.09 $151 - $200
-1 Reduced 0.24%
416 $82,000
Q3 2023

Nov 07, 2023

BUY
$167.14 - $192.77 $5,682 - $6,554
34 Added 8.88%
417 $72,000
Q2 2023

Aug 03, 2023

BUY
$160.94 - $186.23 $1,770 - $2,048
11 Added 2.96%
383 $65,000
Q1 2023

Apr 26, 2023

BUY
$145.48 - $175.02 $25,604 - $30,803
176 Added 89.8%
372 $61,000
Q4 2022

Jan 27, 2023

BUY
$131.14 - $157.47 $4,458 - $5,353
34 Added 20.99%
196 $0
Q3 2022

Oct 24, 2022

SELL
$148.29 - $182.55 $8,600 - $10,587
-58 Reduced 26.36%
162 $24,000
Q2 2022

Jul 19, 2022

BUY
$155.97 - $200.09 $2,963 - $3,801
19 Added 9.45%
220 $38,000
Q1 2022

May 09, 2022

SELL
$181.39 - $234.03 $8,888 - $11,467
-49 Reduced 19.6%
201 $38,000
Q4 2021

Feb 02, 2022

BUY
$193.69 - $247.03 $13,364 - $17,045
69 Added 38.12%
250 $61,000
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $11,168 - $12,371
59 Added 48.36%
181 $35,000
Q2 2021

Aug 03, 2021

BUY
$155.9 - $187.99 $17,460 - $21,054
112 Added 1120.0%
122 $23,000
Q1 2021

May 12, 2021

BUY
$144.0 - $169.39 $1,440 - $1,693
10 New
10 $2,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Mv Capital Management, Inc. Portfolio

Follow Mv Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mv Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mv Capital Management, Inc. with notifications on news.